Explaining the decrease in mortality from abdominal aortic aneurysm rupture
A Anjum, R von Allmen, R Greenhalgh, J T Powell, A Anjum, R von Allmen, R Greenhalgh, J T Powell
Abstract
Background: A steady rise in mortality from abdominal aortic aneurysm (AAA) was reported in the 1980s and 1990 s, although this is now declining rapidly. Reasons for the recent decline in mortality from AAA rupture are investigated here.
Methods: Routine statistics for mortality, hospital admissions and procedures in England and Wales were investigated. All data were age-standardized. Trends in smoking, hypertension and treatment for hypercholesterolaemia (statins), together with regression coefficients for mortality, were available from public sources for those aged at least 65 years. Deaths from ruptured AAA avoided in this age group were estimated by using the IMPACT equation: deaths avoided = (deaths in index year) × (risk factor decline) × β-coefficient.
Results: From 1997, deaths from ruptured AAA have decreased sharply, almost twofold in men. Hospital admissions for elective AAA repair have increased modestly (from 40 to 45 per 100,000 population), attributable entirely to more procedures in those aged 75 years and over (P < 0.001). Admissions for ruptured AAA have declined from 18.6 to 13.5 per 100,000 population, across all ages, with the proportion offered and surviving emergency repair unchanged. From 1997, mortality from ruptured aneurysm in those aged at least 65 years has fallen from 65.9 to 44.6 per 100,000 population. An estimated 8-11 deaths per 100,000 population were avoided by a reduced prevalence of smoking and a similar number from an increase in the number of elective AAA repairs. Estimates for the effects of blood pressure and lipid control are uncertain.
Conclusion: The reduction in incidence of ruptured AAA since 1997 is attributable largely to changes in smoking prevalence and increases in elective AAA repair in those aged 75 years and over.
Copyright © 2012 British Journal of Surgery Society Ltd. Published by John Wiley & Sons, Ltd.
Source: PubMed
Upcoming Clinical Trials
-
Inna Chen, MDHaukeland University Hospital; Azienda Ospedaliera di Padova; Hospital Universitario... and other collaboratorsNot yet recruitingPancreatic CancerDenmark, Italy, Norway, Romania, Spain
-
Guy's and St Thomas' NHS Foundation TrustKing's College London; Breathe Arts Health ResearchNot yet recruitingRehabilitation | Geriatric | Older Adults (65 Years and Older)United Kingdom
-
Assistance Publique - Hôpitaux de ParisNot yet recruiting
-
Fondazione IRCCS Policlinico San Matteo di PaviaRecruitingHeredo Familial Tumors | Psycho Oncological SupportItaly
-
Hansoh BioMedical R&D CompanyNot yet recruitingPlatinum-sensitive Recurrent Ovarian CancerChina
-
Indiana UniversityMoi University; AudereNot yet recruitingAutism Spectrum DisorderUnited States, Kenya
-
Assiut UniversityNot yet recruitingPremature Birth | Bronchopulmonary Dysplasia | Respiration Failure
-
Assiut UniversityNot yet recruitingInflammatory Bowel Diseases | Crohn Disease | Pediatric Crohns Disease
-
Eisai Inc.RecruitingAlzheimer's DiseaseUnited States
-
Emory UniversityNational Institute of Allergy and Infectious Diseases (NIAID)Not yet recruitingHuman Immunodeficiency VirusUnited States
-
AbbVieNot yet recruiting
-
Adraxe Corp.Not yet recruitingEpilepsy (Treatment Refractory)United States